Inspire Medical (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Inspire Medical Systems, Inc. (INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructi
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

's Top Upgrades, Downgrades For April 28, 2020

01:32pm, Tuesday, 28'th Apr 2020
Upgrades B of A Securities changed the rating for AGNC Investment Corp (NASDAQ: AGNC) from Neutral to Buy. AGNC Investment earned $0.57 in the fourth quarter,...
Adverum Biotechnologies (NASDAQ:ADVM) initiated with Buy rating and $17 (36% upside) price target at Goldman Sachs.Alector (NASDAQ:ALEC) initiated with Buy rating and $32 (21% upside) price target at
MINNEAPOLIS, April 28, 2020 -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of.
Assenagon Asset Management S.A. acquired a new stake in Inspire Medical Systems (NYSE:INSP) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The
Inspire Medical Systems (NYSE:INSP) VP Steven Jandrich sold 2,000 shares of the stock in a transaction dated Tuesday, April 21st. The shares were sold at an average price of $72.68, for a total value
Inspire Medical Systems (NYSE:INSP) – Equities researchers at Piper Sandler boosted their Q1 2020 EPS estimates for shares of Inspire Medical Systems in a research report issued on Tuesday, April 21
Piper Sandler began coverage on shares of Inspire Medical Systems (NYSE:INSP) in a research note published on Sunday, The Fly reports. The firm issued an overweight rating and a $74.00 price target on
Following a detailed review of the clinical evidence and iterative discussions with the FDA, Inspire believes that this is the initial step in the pediatric approval process, with further expansion to
Frontier Capital Management Co. LLC raised its holdings in Inspire Medical Systems (NYSE:INSP) by 448.7% in the first quarter, according to the company in its most recent Form 13F filing with the Secu
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE